Case Reports in Pulmonology

Case Reports in Pulmonology / 2016 / Article

Case Report | Open Access

Volume 2016 |Article ID 7452161 |

Faris Hannoodi, Israa Ali, Hussam Sabbagh, Sarwan Kumar, "Streptococcus intermedius Causing Necrotizing Pneumonia in an Immune Competent Female: A Case Report and Literature Review", Case Reports in Pulmonology, vol. 2016, Article ID 7452161, 5 pages, 2016.

Streptococcus intermedius Causing Necrotizing Pneumonia in an Immune Competent Female: A Case Report and Literature Review

Academic Editor: Tun-Chieh Chen
Received15 Apr 2016
Accepted18 Oct 2016
Published06 Nov 2016


We report a case of a 52-year-old immunocompetent Caucasian female treated for necrotizing Streptococcus intermedius pneumonia and review available literature of similar cases. Our patient presented with respiratory failure and required hospitalization and treatment in the intensive care unit. Moreover, she required surgical drainage of right lung empyema as well as decortication and resection. The review of literature revealed three cases of S. intermedius pneumonia, one of which was a mortality. Comparison of the published cases showed a highly varied prehospital course and radiological presentations, with a symptomatic phase ranging from 10 days to five months. Radiological findings varied from an isolated pleural effusion to systemic disease with the presence of brain abscesses. Immunocompetence appears to correlate well with the overall prognosis. In addition, smoking appears to be an important risk factor for S. intermedius pneumonia. In 2 (50%) of cases, pleural fluid analysis identified S. intermedius. In contrast, no organism was found in our patient, necessitating the acquisition of lung tissue sample for the diagnosis. In conclusion, both medical and surgical management are necessary for effective treatment of S. intermedius pneumonia. The outcome of treatment is good in immunocompetent individuals.

1. Introduction

Streptococcus intermedius is part of the Streptococcus anginosus subgroup (formerly Streptococcus milleri) [14]. It is a Gram-positive, catalase negative coccus that is nonmotile and is a facultative anaerobe [5]. They are normally found as part of the oral cavity and the gastrointestinal tract [4, 6, 7]. Although bacteria of the S. anginosus group are known to cause abscesses and systemic infections, S. intermedius pneumonia is rare and there are very few reported cases. We report an interesting case of necrotizing pneumonia in an immunocompetent patient caused by S. intermedius and we also review published cases in the reported literature.

2. Case Summary

A 52-year-old immunocompetent Caucasian female with a past medical history of asthma, that is only treated with albuterol rescue inhaler, and who is also an ex-smoker was transferred from the urgent care clinic to the emergency department (ED). She presented with shortness of breath with minimal activity and low oxygen saturation. Her prior symptoms were coughing and sputum production (greenish, thick, and nonbloody) for 6 weeks. She had been treated for community acquired pneumonia as an outpatient by her primary care physician and in an urgent care clinic. She was initially treated with oral erythromycin for a week. Two weeks following that, she received a week’s course of ciprofloxacin. Her symptoms, however, failed to improve.

Her vitals at presentation were temperature: 99.8°F, HR: 130 BPM, BP: 113/59 mmHg, RR: 36, and SpO2: 84% on room air. She was in severe respiratory distress and unable to complete a sentence without pausing or coughing. Lung exam findings included diminished breath sounds on the right lung base and rhonchi and crackles throughout both lungs on auscultation. ABGs showed pH 7.32, pCO2 33, and pO2 69 on 36% FiO2. The blood test results can be seen in Table 1, most significant of which is the leukocytosis. The extent of the pneumonic process is demonstrated in the images presented in Figure 1.


AG: anion gap and GFR: glomerular filtration rate.

The patient was transferred to the intensive care unit and started empirically on aztreonam, vancomycin, and azithromycin with high flow oxygen. The patient’s blood cultures, fungal cultures, legionella antigen and pleural fluid Gram staining, acid fast staining, and culture were all negative. Decortication, resection of the right upper lung lobe, and drainage of the empyema were performed on the third day of hospitalization and a chest tube was inserted.

Histology of the lung tissue sample showed acute and chronic pneumonitis with large areas of organization, focal abscess formation, and palisaded necrotizing granulomata. Special staining did not show any organisms. Culture of the tissue sample did grow Streptococcus intermedius, however. The organism was penicillin sensitive, but the patient has penicillin allergy. She was therefore given IV ceftriaxone, since beta-lactams have higher efficacy against streptococci than vancomycin. The patient was treated for a total of 14 days in hospital with IV antibiotics, of which, 7 days were in the intensive care unit.

3. Discussion

A search through PubMed and Google Scholar yielded only three reported cases of pneumonia caused by S. intermedius. All of the published cases are of male patients. 2 (67%) of the published cases are for patients in their 50s. Our case appears to be the only female patient. The immunocompetence of two of the reported cases is not mentioned. One case states the patient denies having risk factors for HIV [10]. Alcoholic liver cirrhosis is noted to be one of the conditions in one of the patients [9], which is a predisposing factor to infection as it leads to immune system dysfunction and relative immunoincompetence [11] (refer to Table 2).

CaseOur case1 [8]2 [9]3 [10]

Radiological diagnosisBilateral pneumonia, loculated right pleural effusionLeft upper lobe pneumonia and left pleural empyemaRight upper lobe pneumonia, bilateral brain abscessesLoculated left pleural effusion
Duration of respiratory symptoms6 weeks10 days5 months
Past medical historyAsthmaSurgical drainage of right empyema 4 months priorAlcoholic liver cirrhosisHypertension, hyperlipidemia, and poor dental hygiene
Smoker statusEx-smokerEx-smokerActive smoker
Systolic blood pressure (mmHg)113104125
Heart rate11011893
Respiratory rate36
Oxygen saturations84% on room air93% on 3 L
Temperature99.8°F (37.7°C)101.1°F (38.4°C)101.3°F (38.5°C)98.0°F (36.7°C)
Initial WBC29.239.6Normal (no number given)
Initial empiric antibioticsAztreonam, vancomycin + azithromycinMeropenemCeftriaxone + ampicillinLevofloxacin + clindamycin
Targeted antibioticsCeftriaxoneMeropenemLevofloxacin
Total duration of antibiotics14 days14 days24
Surgical interventionDecortication, resection of right upper lung lobe and chest tube insertionLeft pleurectomy and chest tube insertionVideo-assisted thoracoscopic biopsyThoracocentesis and chest tube insertion

The duration of symptoms for S. intermedius prior to hospitalization is highly variable, ranging from 10 days to 5 months. In one of the cases, the patient had empyema drained 4 months prior to presentation, though the responsible organism is not mentioned [8]. The radiological findings were also varied, ranging from presence of isolated pleural effusion to pneumonia with abscesses. This is consistent with the organism’s property of causing local as well as systemic abscesses [6, 7].

As we can see in Table 2, there is one risk factor that most of the cases appear to share: a history of smoking. In general, smoking is a risk factor for pulmonary infections as it impairs ciliary function and increases mucous increases [12]. The patients appear to be hemodynamically stable on presentation, but they also have respiratory compromise and meet the criteria for a positive systemic inflammatory response. Fever is not always present even in severe respiratory disease as demonstrated in our case, neither is an elevated WBC as seen in one of the reported cases [10].

Treatment duration with antibiotics in our case and in one of the reported cases was 14 days, though in another it was 24 days [10]. S. intermedius appears to be sensitive to beta-lactam antibiotics, though some cases of resistance have been reported [13]. In penicillin allergic patients, vancomycin is suggested as an alternative [14]. All the patients had a form of procedural intervention performed. This is expected as 3 (75%) of the patients had empyema with some form of loculation that necessitated drainage. Only one (25%) of the patients in the reported cases died from the pneumonia. This may be attributable to the concomitant presence of brain abscesses and liver cirrhosis [9].

As presented in Table 3, all of the cases that had a pleural fluid sample from the patient show it to be an exudate as LDH is >1000, meeting Light’s criteria as well as the two-test and three-test rules [15, 16]. In both cases 1 and 3, organisms were identified in pleural fluid culture. In case 1, S. intermedius was identified following PCR and a homology search on the culture of the pleural fluid. In contrast, no organisms were identified in either pleural fluid microscopy or culture from the sample taken from our patient. The diagnosis was instead made by lung tissue sample culture. This shows that even when no organism is identified in the pleural fluid, S. intermedius can still be the etiologic agent. In both case and in our case, histology of the lung tissue revealed necrotizing pneumonia, signifying the severity of disease caused by this organism (refer to Table 3).

CaseOur case1 [8]2 [9]3 [10]

Total protein (g/dL)
Glucose (mg/dL)931.010
Gram stainingNo organismsNo organisms
Pleural fluid cultureNo growthS. anginosus groupS. intermedius
Tissue histologyNecrotizing pneumonia, culture: S. intermediusNecrotizing pneumonia, culture: S. intermedius

Case did not have a pleural fluid sample; S. anginosus: Streptococcus anginosus.

4. Conclusion

To sum up, Streptococcus intermedius pneumonia has a wide-ranging prehospital incubation period, presentation, and radiological findings. Nonetheless, it is clear from both our case and the reported cases that S. intermedius causes severe disease that requires medical as well as surgical management to be treated effectively. Moreover, if pleural fluid microscopy and culture are negative, efforts should be made to obtain a lung tissue sample for microscopy and culture to identify the bacterium. Despite the severity of the disease, S. intermedius pneumonia shows good sensitivity to broad-spectrum antibiotics such as beta-lactams. As a result, patients have a good prognosis provided that they are immunocompetent.

Competing Interests

The authors declare no competing interests.

Authors’ Contributions

Faris Hannoodi was the main author, drafted most of the manuscript, and reviewed published literature, Israa Ali helped in drafting manuscript, Hussam Sabbagh helped in drafting manuscript, and Sarwan Kumar helped in drafting manuscript and revised its material. All authors read and approved the final manuscript.


  1. K. L. Ruoff, “Streptococcus anginosus (‘Streptococcus milleri’): the unrecognized pathogen,” Clinical Microbiology Reviews, vol. 1, no. 1, pp. 102–108, 1988. View at: Publisher Site | Google Scholar
  2. R. A. Whiley and D. Beighton, “Emended descriptions and recognition of Streptococcus constellatus, Streptococcus intermedius, and Streptococcus anginosus as distinct species,” International Journal of Systematic and Evolutionary Microbiology, vol. 41, no. 1, pp. 1–5, 1991. View at: Google Scholar
  3. R. A. Whiley, D. Beighton, T. G. Winstanley, H. Y. Fraser, and J. M. Hardie, “Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections,” Journal of Clinical Microbiology, vol. 30, no. 1, pp. 243–244, 1992. View at: Google Scholar
  4. J. E. Clarridge III, S. Attorri, D. M. Musher, J. Hebert, and S. Dunbar, “Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (‘Streptococcus milleri group’) are of different clinical importance and are not equally associated with abscess,” Clinical Infectious Diseases, vol. 32, no. 10, pp. 1511–1515, 2001. View at: Publisher Site | Google Scholar
  5. R. A. Whiley, H. Fraser, J. M. Hardie, and D. Beighton, “Phenotypic differentiation of Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus strains within the ‘Streptococcus milleri group’,” Journal of Clinical Microbiology, vol. 28, no. 7, pp. 1497–1501, 1990. View at: Google Scholar
  6. B. Mejàre, “Characteristics of Streptococcus milleri and Streptococcus mitior from infected dental root canals,” Odontologisk Revy, vol. 26, no. 4, pp. 291–308, 1975. View at: Google Scholar
  7. M. T. Parker and L. C. Ball, “Streptococci and aerococci associated with systemic infection in man,” Journal of Medical Microbiology, vol. 9, no. 3, pp. 275–302, 1976. View at: Publisher Site | Google Scholar
  8. S. Noguchi, K. Yatera, T. Kawanami et al., “Pneumonia and empyema caused by Streptococcus intermedius that shows the diagnostic importance of evaluating the microbiota in the lower respiratory tract,” Internal Medicine, vol. 53, no. 1, pp. 47–50, 2014. View at: Publisher Site | Google Scholar
  9. R. Khatib, J. Ramanathan, and J. Baran Jr., “Streptococcus intermedius: a cause of lobar pneumonia with meningitis and brain abscesses,” Clinical Infectious Diseases, vol. 30, no. 2, pp. 396–397, 2000. View at: Publisher Site | Google Scholar
  10. S. B. Iskandar, M. A. Al Hasan, T. M. Roy, and R. P. Byrd Jr., “Streptococcus intermedius: an unusual cause of a primary empyema,” Tennessee Medicine: Journal of the Tennessee Medical Association, vol. 99, no. 2, pp. 37–39, 2006. View at: Google Scholar
  11. M. Dirchwolf, A. Podhorzer, M. Marino et al., “Immune dysfunction in cirrhosis: distinct cytokines phenotypes according to cirrhosis severity,” Cytokine, vol. 77, pp. 14–25, 2016. View at: Publisher Site | Google Scholar
  12. T. W. Marcy and W. W. Merrill, “Cigarette smoking and respiratory tract infection,” Clinics in Chest Medicine, vol. 8, no. 3, pp. 381–391, 1987. View at: Google Scholar
  13. M. Tracy, A. Wanahita, Y. Shuhatovich, E. A. Goldsmith, J. E. Clarridge III, and D. M. Musher, “Antibiotic susceptibilities of genetically characterized Streptococcus milleri group strains,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 5, pp. 1511–1514, 2001. View at: Publisher Site | Google Scholar
  14. C. Bantar, L. F. Canigia, S. Relloso, A. Lanza, H. Bianchini, and J. Smayevsky, “Species belonging to the ‘Streptococcus milleri’ group: antimicrobial susceptibility and comparative prevalence in significant clinical specimens,” Journal of Clinical Microbiology, vol. 34, no. 8, pp. 2020–2022, 1996. View at: Google Scholar
  15. R. W. Light, M. I. Macgregor, P. C. Luchsinger, and W. C. Ball Jr., “Pleural effusions: the diagnostic separation of transudates and exudates,” Annals of Internal Medicine, vol. 77, no. 4, pp. 507–513, 1972. View at: Publisher Site | Google Scholar
  16. J. E. Heffner, L. K. Brown, and C. A. Barbieri, “Diagnostic value of tests that discriminate between exudative and transudative pleural effusions,” Chest, vol. 111, no. 4, pp. 970–980, 1997. View at: Publisher Site | Google Scholar

Copyright © 2016 Faris Hannoodi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.